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Introduction
A circadian variation in the frequency of onset of acute 
myocardial infarction (AMI) has been reported in a number   
of studies over the past several decades. A majority of large-
scale reports have shown a peak incidence in morning hours, 
although a secondary peak incidence in the late evening has 
sometimes been reported.
1-7) The higher incidence of ST-
segment elevation myocardial infarction (STEMI) in early 
morning has been explained by changes in catecholamine lev-
els, fibrinolytic activity, blood pressure, platelet aggregability, 
coronary tone, and endothelial function.
4)5)8-10) Differences in 
the circadian variation of AMI in different regions of the world 
and in different ethnic groups have also been reported.
4)5)7)11) 
Although associations between the time of onset of AMI and 
in-hospital or 30-day mortality were suggested in some previous 
studies,
12)13) not much is known about the 12- month mortality of 
AMI, including STEMI and non-STEMI (NSTEMI). The aim 
of this study was to investigate the impact of circadian variation 
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ABSTRACT
Background and Objectives: Although circadian variation in the onset of acute myocardial infarction (AMI) has been re-
ported in a number of studies, not much is known about the impact of circadian variation on 12-month mortality. The aim 
of this study was to investigate the impact of circadian variation on 12-month mortality in patients with AMI. Subjects and 
Methods: Eight hundred ninety two patients (mean age 67±12; 66.1% men) with AMI who visited Kyungpook National 
University Hospital from November 2005 to December 2007 were included in this study. Patients were divided into groups 
based on four 6-hours intervals: overnight (00:00-05:59); morning (06:00-11:59); afternoon (12:00-17:59) and evening 
(18:00-23:59). Results: Kaplan-Meier survival curves showed 12-month mortality rates of 9.6%, 9.1%, 12.1%, and 16.7% in 
the overnight, morning, afternoon, evening-onset groups, respectively (p=0.012). Compared with the morning-onset AMI 
group, the serum creatinine levels (p=0.002), frequency of Killip class ≥3 (p=0.004), and prescription rate of diuretics 
(p=0.011) were significantly higher in the evening-onset AMI group, while the left ventricular ejection fraction (p=0.012) 
was significantly lower. The proportion of patients who arrived in the emergency room during routine duty hours was signifi-
cantly lower in evening-onset groups irrespective of the presence or absence of ST-segment elevation (p<0.001). According 
to univariate analysis, the 12-month mortality rate in the evening group was significantly higher compared to the morning 
group (hazard ratio 1.998, 95% confidence interval 1.196 to 3.338, p=0.008). Conclusion: Patients with evening-onset AMI 
had poorer baseline clinical characteristics, and this might affect the circadian impact on 12-month mortality. Further stud-
ies are needed to clarify the role of circadian variation on the long-term outcome of AMI. (Korean Circ J 2010;40:616-624)
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on 12-month mortality in patients with AMI. 
Subjects and Methods 
Study patients
We included 966 consecutive patients with AMI who were 
admitted to Kyungpook National University Hospital between 
November 2005 and December 2007. A diagnosis of AMI was 
made in patients having angina pain lasting more than 15 min-
utes that was associated with/without dyspnea or sweating, es-
tablished/evolving ST-T wave changes on serial electrocardio-
grams, and an increase in levels of cardiac troponin I (cTnI). 
cTnI levels were measured on admission and every 6 hours to 
detect the presence of myocardial injury, using an enzyme im-
munoassay based on the sandwich principle (Dimension; Dade 
Behring, Deerfield, IL, USA); the lower detection limit of this 
assay was 0.04 ng/mL. Elevated cardiac biomarker levels were 
defined as having maximal values of cTnI that exceeded the 
cutoff (99th percentile of the values for a reference control gr-
oup) on at least one occasion. The time of onset of AMI was 
determined by each patient’s report of the chest pain that pro-
mpted hospital admission. Seventy-four patients with unclear 
onset of chest pain, including silent AMI, were excluded from 
further analysis. In total, 892 patients (mean age 67±12 years; 
66.1% men) were included in this study. Informed consent 
was obtained from each patient. 
Data analyses
Each day was divided into 12 equal parts of two hours each, 
and patients were grouped according to the time of symptom 
onset. For further analysis, a day was divided again into four 
equal 6-hour intervals: overnight (00:00 AM-05:59 AM); 
morning (06:00 AM-11:59 AM); afternoon (12:00 PM-17:59 
PM) and evening (18:00 PM-23:59 PM).
2)14) Routine duty ho-
urs were defined as Monday to Friday between 08:00 AM and 
18:00 PM.
13) Weekends were considered off-duty hours. We an-
alyzed the baseline demographic characteristics, initial presen-
tation, initial vital signs, results of laboratory tests, and dis-
charge medications of the patients. Demographic and clinical 
characteristics were identified, including age, gender, body 
mass index (BMI), cardiovascular risk factors (hypertension, 
diabetes mellitus, hyperlipidemia, and current smoking), and 
co-morbidities, which indluded previous congestive heart 
failure and myocardial infarction (MI). Initial vital signs in-
cluding the systolic pressure and Killip class were evaluated 
at admission. Initial blood samples collected at admission, 
except for those collected to determine peak cTnI, were used 
for baseline laboratory tests. The left ventricular ejection frac-
tion (LVEF) was determined by 2-dimensional echocardiog-
raphy during the index hospitalization. The mean symptom-
to-door time (STD) and the proportion of patients with STD 
time ≥6 hours were assessed in patients with typical chest pain. 
In patients with STEMI, the median door-to-balloon (DTB) time 
and the proportion of patients with DTB time ≤90 minutes 
were also evaluated. Discharge medications assessed includ-
ed aspirin, β-blockers, angiotensin converting enzyme in-
hibitors (ACE-I)/angiotensin receptor blockers (ARB), and 
diuretics. Mean follow-up duration was 357±141 days. The 
primary end-point was 12-month mortality, including both 
cardiac death and non-cardiac death. Cardiac death was de-
fined as death from pump failure, arrhythmia, or mechanical 
complications, which included ventricular septal rupture and 
free wall rupture. During the follow-up period, data were ob-
tained by reviewing medical records and by telephone inter-
view with the patients.
Statistical analyses
Chi-squared goodness-of-fit was performed to test the 
uniformity of the distribution of patients among the time 
periods. Data are expressed as mean±SD for continuous vari-
ables and percentages for categorical variables. All compari-
sons between baseline variables were assessed with the anal-
Fig. 1. The circadian variation of the onset of AMI for the total 
study population obtained at 2-hour intervals. The distribution is not 
uniform (p<0.001) and a peak occurring between 8:00 and 9:59 
hours was statistically significant (p<0.001). AMI: acute myocardial 
infarction.
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Fig. 2. The circadian variation of the onset of AMI for the total study 
population obtained at 6-hour intervals. A morning peak was sta-
tistically significant (p<0.001). In contrast, the 12-month mortality 
rate was significantly higher in the evening-onset AMI group (p= 
0.012). AMI: acute myocardial infarction.618   Circadian Variation on Mortality in AMI
ysis of variance for continuous variables, and with the Pearson’s 
Chi-square test for categorical variables. A multivariate lo-
gistic regression model was used to determine independent 
predictors for evening-onset AMI. Twelve-month mortality 
according to the onset time of AMI was evaluated using Ka-
plan-Meier survival curve analysis. Univariate analyses were 
performed to determine the clinical predictors of 12-month 
mortality. The Cox proportional hazard model was used to 
calculate the risk of 12-month mortality related to the time of 
onset of AMI, and adjusted for baseline confounding charac-
teristics. For all analyses, a two-sided p<0.05 was considered 
statistically significant. Statistical analysis was performed using 
SPSS version 15.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Circadian variation in the onset of acute myocardial 
infarction
The frequency of the onset of AMI as determined by onset 
of chest pain for all 892 patients is shown in Fig. 1. The distri-
bution is not uniform (p<0.001), and a peak was found be-
tween 08:00 and 09:59 hours (p<0.001). The distribution of 
AMI onset was obtained for each 6-hour interval, and a mo-
rning peak was found to be statistically significant (p<0.001) 
(Fig. 2). The numbers of patients grouped according to the 
AMI onset time were 184 (20.6%), 303 (34.0%), 187 (21.0%), 
and 218 (24.4%), corresponding to overnight, morning, after-
Table 1. Clinical characteristics of patients according to the hour of onset of AMI 
Overall
(n=892)
Overnight
(n=184)
Morning
(n=303)
Afternoon
(n=187)
Evening
(n=218)
p* p†
Demographics
Age (years) 066.8±12.0 65.7±13.3 66.8±11.5 67.4±11.0. 67.0±12.5 0.553 0.999
Age ≥65 (%) 59.6 56.0 59.4 62.0 61.0 0.275 0.712
Male (%) 66.1 63.6 65.0 67.9 68.3 0.245 0.427
Body mass index (kg/m
2) 023.7±3.00 24.0±3.10 23.6±2.90 23.4±3.10. 23.7±2.90 0.421 0.979
Initial presentation
Systolic blood pressure (mmHg) 136.9±29.4 139.1±27.50 136.6±29.30 134.8±30.10. 137.3±30.40 0.562 0.992
Anterior myocardial infarction (%) 53.2 60.1 48.0 53.8 54.2 0.652 0.216
Killip class ≥3 (%) 17.5 16.9 12.6 20.9 22.0 0.027 0.004
Preinfarct angina pectoris (%) 47.0 53.3 45.9 47.6 42.7 0.193 0.467
Mean STD time (minute) 00564±1,157 0618±1,155 0567±1,463 0587±1,076 496±624 0.746 0.923
STD time ≥6 hour (%) 36.3 40.8 36.0 32.1 36.7 0.348 0.865   
ER arrival during routine duty-hours (%) 42.0 33.7 70.0 35.3 16.1 <0.001 <0.001
Past history (%)
Diabetes mellitus  26.8 23.4 27.1 24.1 31.8 0.108 0.241
Hypertension  44.8 45.1 43.4 41.7 49.3 0.411 0.181
Hyperlipidemia 23.1 24.2 24.3 21.8 21.5 0.436 0.484
Myocardial infarction 12.4 16.1 10.7 09.6 14.0 0.719 0.427
Current smoker 44.9 43.4 44.9 43.5 47.5 0.479 0.556
LVEF (%) 052.1±10.5 52.4±10.4 53.4±9.70 51.9±10.6 50.1±11.4 0.011 0.012
PCI at index hospitalization (%) 71.6 73.9 71.0 75.4 67.4 0.284 0.440
Laboratory findings
Creatinine (mg/dL) 01.1±1.1 1.0±1.1 1.0±0.8 1.0±0.6 1.3±1.6 0.001 0.002
Cardiac Troponin I (ng/mL) 0055.7±312.5 34.5±52.0 049.5±103.0 41.5±89.4 094.4±612.7 0.197 0.457
Log proBNP (pg/mL) 02.6±0.8 2.6±0.8 2.6±0.8 2.6±0.8 2.7±0.9 0.157 0.532
Discharge medication (%)
Aspirin 94.8 94.8 95.4 94.8 93.9 0.594 0.459
β-blockers 86.3 89.1 85.9 84.4 86.2 0.421 0.911
ACE-I/ARBs 89.2 90.8 89.8 87.8 88.3 0.350 0.607
Diuretics 26.0 25.9 22.3 24.9 29.8 0.073 0.011
*p for all comparisons, †p for the morning vs. evening group. AMI: acute myocardial infarction, STD: symptom-to-door, ER: emergency room, 
LVEF: left ventricular ejection fraction, PCI: percutaneous coronary intervention, proBNP: pro-brain natriuretic peptide, ACE-I/ARB: angio-
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noon and evening-onset groups, respectively. The incidence 
of morning-onset AMI was 54% higher than the average of 
the three other time periods. A morning peak of AMI was 
found irrespective of the presence or absence of ST-segment 
elevation (p=0.001 in STEMI and p<0.001 in NSTEMI).
Clinical characteristics of patients according to 
acute myocardial infarction onset
The clinical characteristics of the patients are shown in Ta-
ble 1. The patients mean age was 67±12 years, and 590 (66.1%) 
were men. There were no significant differences in age, sex, 
BMI, systolic blood pressure, preinfarct angina pectoris, lo-
cation of AMI, previous history of diabetes mellitus, hyper-
tension, hyperlipidemia, MI, use of tobacco, percutaneous cor-
onary intervention (PCI) at index hospitalization, peak cTnI, 
or pro-brain natriuretic peptide (proBNP) levels among the 
four groups. In the evening-onset AMI group serum creatinine 
levels (p=0.001) and the frequency of Killip class ≥3 (p=0.027) 
Table 2. Clinical characteristics of patients according to the hour of onset of STEMI 
Overall
(n=403)
Overnight
(n=86)
Morning
(n=134)
Afternoon
(n=82)
Evening
(n=101)
p* p†
Demographics
Age (years) 65.7±11.8 64.8±12.0 65.9±11.5 65.9±10.8 66.0±12.8 0.888 0.973
Age ≥65 (%) 55.8 54.7 57.5 53.7 56.4 0.967 0.875
Male (%) 69.0 65.1 65.7 72.0 74.3 0.104 0.158
BMI (Kg/m
2) 23.7±3.00 23.8±2.9 23.6±3.20 23.3±2.70 24.2±2.70 0.257 0.130
Initial presentation
Systolic blood pressure (mmHg) 130.3±28.60 134.1±28.00 128.7±27.90 127.7±30.20 131.4±28.70 0.438 0.471
Anterior myocardial infarction (%) 55.0 61.9 46.5 57.5 58.3 0.809 0.079
Killip class ≥3 (%) 15.2 15.3 13.4 15.9 16.8 0.626 0.469
Preinfarct angina pectoris (%) 37.2 44.2 38.1 36.6 30.7 0.298 0.241
Mean STD time (minute) 419±573 455±671 350±484 409±474 487±657 0.294 0.080
STD time ≥6 hour (%) 31.0 36.0 28.4 25.6 34.7 0.889 0.302
Median DTB time, median 
  (range in minute) 
80
(23-14,065)
114 
(34-12,636)
75 
(23-14,065)
81 
(27-11,240)
121
 (32-13,700)
0.039 0.011
DTB time ≤90 minute (%) 50.3 43.6 58.3 54.7 41.5 0.555 0.020
ER arrival during routine 
  duty-hours (%)
40.9 26.7 70.1 40.2 14.9 <0.001 <0.001
Past history (%)
Diabetes mellitus 23.4 19.8 21.6 18.3 33.0 0.049 0.051
Hypertension 39.2 38.4 38.1 30.5 48.5 0.245 0.109
Hyperlipidemia 21.3 26.9 22.1 14.1 20.9 0.226 0.518
Myocardial infarction 06.8 07.0 07.5 06.8 05.9 0.791 0.427
Current smoker 49.9 45.3 49.2 57.3 48.5 0.506 0.912
LVEF (%) 51.2±10.4 51.9±10.7 51.8±9.40 51.2±11.0 49.8±11.1 0.527 0.169
PCI at index hospitalization (%) 88.1 91.9 88.1 91.5 82.2 0.079 0.205
Laboratory findings
Creatinine (mg/dL) 0.9±0.6 0.8±0.3 0.9±1.0 0.9±0.2 1.0±0.6 0.354 0.590
Cardiac Troponin I (ng/mL) 102.0±457.5 54.8±59.9 096.0±140.0 082.7±122.5 166.4±893.2 0.383 0.372
Log proBNP (pg/mL) 2.5±0.8 2.4±0.8 2.6±0.8 2.3±0.8 2.6±0.8 0.247 0.970
Discharge medication (%)
Aspirin 97.8 100.0 97.5 96.0 97.7 0.281 0.647
β-blockers 89.0 92.6 86.0 88.0 90.9 0.954 0.275
ACE-I/ARBs 93.4 96.3 93.4 88.0 95.5 0.583 0.526
Diuretics 22.7 21.0 21.5 18.7 29.5 0.234 0.183
*p for all comparison, †p for the morning vs. evening group. STEMI: ST-segment elevation myocardial infarction, BMI: body mass index, STD: 
symptom-to-door, DTB: door-to-balloon, ER: emergency room, LVEF: left ventricular ejection fraction, PCI: percutaneous coronary inter-
vention, proBNP: pro-brain natriuretic peptide, ACE-I/ARB: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker620   Circadian Variation on Mortality in AMI
were significantly higher, while the LVEF (p=0.011) was sig-
nificantly lower. The mean STD time was 564±1,157 minutes, 
with no significant differences in the mean STD time (p= 
0.746) or the proportion of patients with an STD time ≥6 
hours (p=0.384) among the four groups. The proportion of pa-
tients who arrived in the emergency room (ER) during routine 
duty hours was significantly higher in the morning-onset AMI 
group (p<0.001). The discharge prescription rates of aspirin, 
β-receptor blockers, ACE-I/ARBs, and diuretics were not sig-
nificantly different among the four groups.
Compared with the morning-onset AMI group, serum 
creatinine levels (p=0.002),the frequency of Killip class ≥3 
(p=0.004), and the prescription rate of diuretics (p=0.011) were 
significantly higher in the evening-onset AMI group, while 
LVEF (p=0.012) was significantly lower. The proportion of pa-
tients who arrived in the ER during routine duty hours was 
significantly lower in the evening-onset group compared to 
the morning-onset group (p<0.001). 
Subgroup analysis 
In the STEMI group (Table 2), the numbers of patients with 
a previous history of diabetes mellitus was significantly high-
er within the evening-onset group (p=0.049). The median DTB 
time was 80 minutes, and was significantly longer in the over-
night-onset and evening-onset groups than in the morning-
onset and afternoon-onset groups (p=0.039). The proportion 
Table 3. Clinical characteristics of patients according to the hour of onset of NSTEMI 
Overall
(n=489)
Overnight
(n=98)
Morning
(n=169)
Afternoon
(n=105)
Evening
(n=117)
p* p†
Demographics
Age (years) 67.6±12.2 66.5±14.4 67.6±11.5 68.6±11.1 67.9±12.1 0.659 0.815
Age ≥65 (%) 62.8 57.1 60.9 68.6 65.0 0.142 0.491
Male (%) 63.8 62.2 64.5 64.8 63.2 0.913 0.829
BMI (Kg/m
2) 23.7±3.00 24.1±3.20 23.7±2.60 23.5±3.30 23.3±2.90 0.294 0.346
Initial presentation
Systolic blood pressure (mmHg) 142.3±28.90 143.6±26.40 142.8±28.90 140.3±28.90 142.4±31.00 0.863 0.907
Anterior myocardial infarction (%) 51.2 58.0 49.6 50.0 48.6 0.332 0.896
Killip class ≥3 (%) 19.5 18.4 11.9 24.8 26.5 0.013 0.002
Preinfarct angina pectoris (%) 55.0 61.2 52.1 56.2 53.0 0.499 0.878
Mean STD time (minute) 0685±1,463 761±1,442 0740±1,896 0726±1,360 504±597 0.500 0.195
STD time ≥6 hour (%) 40.7 44.9 42.0 37.1 38.5 0.258 0.548
ER arrival during routine duty-hours (%) 42.9 39.8 69.8 31.4 17.1 <0.001 <0.001
Past history (%)
Diabetes mellitus 29.7 26.5 31.4 28.6 30.8 0.108 0.915
Hypertension 49.5 51.0 47.6 50.5 50.0 0.951 0.693
Hyperlipidemia 24.6 21.5 26.2 27.7 22.0 0.998 0.451
Myocardial infarction 17.6 24.0 13.3 12.8 22.4 0.953 0.171
Current smoker 40.6 33.3 40.2 44.2 44.0 0.107 0.531
LVEF (%) 52.8±10.5 52.8±10.1 54.6±9.80 52.5±10.2 50.4±11.7 0.017 0.003
PCI at index hospitalization (%) 58.1 58.2 57.4 62.9 54.7 0.798 0.651
Laboratory findings
Creatinine (mg/dL) 1.2±1.3 1.1±1.5 1.0±0.6 1.1±0.7 1.6±2.1 0.001 0.001
Peak cardiac Troponin I (ng/mL) 17.6±53.9 16.7±35.5 12.7±21.9 09.4±15.1 32.8±99.6 0.004 0.034
Log proBNP (pg/mL) 2.7±0.8 2.7±0.7 2.7±0.8 2.7±0.8 2.9±0.9 0.193 0.048
Discharge medication (%)
Aspirin 92.4 90.3 93.8 93.9 90.7 0.971 0.343
β-blockers  84.2 86.0 85.8 81.6 82.4 0.335 0.451
ACE-I/ARBs  85.9 86.0 87.0 87.6 82.4 0.456 0.294
Diuretics 28.6 30.1 22.8 29.6 35.2 0.182 0.027
*p for all comparison, †p for the morning vs. evening group. NSTEMI: non-STEMI, BMI: body mass index, STD: symptom-to-door, ER: emergency 
room, LVEF: left ventricular ejection fraction, PCI: percutaneous coronary intervention, proBNP: pro-brain natriuretic peptide, ACE-I/ARB: 
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of all patients with a DTB time ≤90 minutes was not signifi-
cantly different among the four groups. However, compared 
with the morning-onset STEMI group, the proportion of pa-
tients with a DTB time ≤90 minutes was significantly lower for 
the evening-onset STEMI group (p=0.039). Serum creatinine 
levels, frequency of Killip class ≥3, and LVEF were not differ-
ent among four STEMI groups. 
In the NSTEMI group (Table 3), the frequency of Killip class 
≥3 (p=0.013), levels of serum creatinine (p=0.001), and peak 
cTnI (p=0.004) were significantly higher in the evening-onset 
NSTEMI group, while the LVEF (p=0.017) was significantly 
lower. Compared with the morning-onset NSTEMI group, the 
log proBNP level (p=0.048), prescription rate of diuretics (p= 
0.027), frequency of Killip class ≥3, levels of serum creatinine, 
and peak cTnI were significantly different in the evening-on-
set NSTEMI group. The proportion of patients who arrived in 
the ER during routine duty hours was significantly lower in the 
evening-onset group, irrespective of the presence or absence of 
ST-segment elevation (p<0.001).
Twelve-month mortality
During the study period, 48 (5.4%) patients were lost dur-
ing follow-up. The overall mortality rate was 11.7% (n=99), with 
10.5% (n=89) from cardiac deaths and 1.2% (n=10) from non-
cardiac deaths. No significant difference in the 12-month mor-
tality rate was observed between STEMI and NSTEMI groups 
(11.6% vs. 11.8%, p=NS). Kaplan-Meier survival curves showed 
12-month mortality rates of 9.6% (n=17), 9.1% (n= 26), 12.1% 
(n=21) and 16.7% (n=35) in the overnight, morning, after-
noon and evening-onset groups, respectively (p= 0.012) (Figs. 
2 and 3). Although there were no significant differences in in-
hospital mortality among the four groups according to univari-
A  
C  
B  
Fig. 3. Kaplan-Meier survival curves for 12-month mortality accord-
ing to onset time in patients with all AMI (A), STEMI (B), and NSTE-
MI (C). In patients with AMI and NSTEMI, 12-month mortality rates 
in the evening-onset groups were significantly higher than those in 
the morning-onset groups. AMI: acute myocardial infarction, STEMI: 
ST-segment elevation myocardial infarction, NSTEMI: non-STEMI. 
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ate analysis, 6-month (p=0.006) and 12-month mortality rates 
(p=0.012) were significantly higher in the evening-onset 
group than for the three other groups. Compared with the 
morning onset-AMI group, 6-month {hazard ratio (HR) 
2.040, 95% CI 1.181 to 3.523, p=0.011} and 12- month mortali-
ty rates [HR 1.998, 95% confidence interval (CI) 1.196 to 3.338, 
p= 0.008] were significantly higher in the evening onset-AMI 
group (Table 4). A similar result was obtained for 12-month 
mortality in patients with NSTEMI. However there were no 
significant differences between morning- and evening-onset 
STEMI groups in in-hospital, 6-month, and 12-month mor-
tality rates. According to the multivariate Cox proportional-
hazards model, evening-onset AMI (HR 0.518, 95% Cl 0.168 to 
1.601, p=0.253) was not an independent predictor for 12-month 
mortality after adjusting for age, gender, ER arrival during off-
duty hours, LVEF, Killip class ≥3, prescription of diuretics, lev-
els of serum creatinine, peak cTnI, and log proBNP.
Discussion
The main finding in this single center observational study 
is that 12-month mortality in patients with evening-onset 
AMI was significantly higher than that in the morning-onset 
AMI group. This was due to poorer baseline clinical charac-
teristics for evening-onset AMI patients. In this study circadi-
an variation of 12-month mortality might be secondary to dif-
ferences in baseline characteristics at the onset time of AMI. 
Killip class and serum creatinine levels have an impact on 
clinical outcome as surrogates for heart failure and acute renal 
failure after AMI.
15-18) In this study, patients with Killip class 
≥3, higher levels of serum creatinine, and lower LVEF were 
found significantly more frequent in evening-onset AMI group 
compared to the three other onset groups. In a study on the 
determinants of MI onset, Mukamal et al.
14) showed that the 
risk of heart failure was highest in patients with infarctions 
that began between 6 PM and midnight and midnight to 6 
AM. In another study, the peak between 6 PM and midnight 
was most pronounced, with patients with a history of conges-
tive heart failure experiencing greater onset of MI.
2) Although 
the mechanisms underlying these findings were not clear from 
their study, in this study newly developed heart failure follow-
ing AMI, or underlying heart failure might affect the evening 
peak of 12-month mortality. Poor baseline clinical character-
istics including Killip class ≥3, lower LVEF, higher levels of se-
rum creatinine, and peak cTnI were also found in the evening-
onset NSTEMI group. However, there were no significant 
differences in baseline clinical characteristics, except for dia-
betes mellitus, among the four STEMI groups. An evening 
peak of 12-month mortality was shown in the NSTEMI group, 
but was not demonstrated in the STEMI group. We hypothe-
sized the differences in the baseline characteristics between 
the STEMI and NSTEMI groups might explain the difference 
in 12-month mortality between the two groups.
Outcomes after primary PCI have been reported to be re-
lated to the time delay from symptom onset to first-balloon 
inflation,
19) and to hospital volume.
20-22) In this study, the mean 
STD time was 564 minutes, and one third of patients had STD 
time ≥6 hours. There were no significant differences in STD 
time among the four groups. About 70% of patients in the 
morning-onset AMI group arrived at the ER during routine 
duty hours. However, only 16% of patients in the evening-on-
set AMI group arrived at the ER during routine duty hours. It 
is well known that patients presenting with AMI during off-du-
ty hours have higher in-hospital mortality than patients pre-
senting during routine duty hours.
12)13)23)24) However, quality of 
care is difficult to measure, and it is unclear whether this affect-
Table 4. In-hospital, 6-month, and 12-month mortality rates according to the hour of onset of AMI
Overall
(n=844)
Overnight
(n=177)
Morning
(n=285)
Afternoon
(n=173)
Evening
(n=209)
p*
Evening vs. 
morning
p†
In-hospital mortality (%) OR (95% CI)
All AMI 4.7 3.8 4.6 3.7 6.4 0.281 1.417 (0.661-3.036) 0.370
STEMI 6.7 4.7 7.5 3.7 9.9 0.293 1.363 (0.544-3.410) 0.509
NSTEMI 3.1 3.1 2.4 3.8 3.4 0.692 1.460 (0.358-5.959) 0.598
6-month mortality (%) HR (95% Cl)
All AMI 9.9 7.4 7.6 10.40 14.90 0.006 2.040 (1.181-3.523) 0.011
STEMI 10.70 7.4 10.00 7.4 17.20 0.055 1.762 (0.856-3.629) 0.124
NSTEMI 9.2 8.3 5.6 12.50 12.60 0.086 2.371 (1.026-5.480) 0.043
12-month mortality (%) HR (95% Cl)
All AMI 11.70 9.6 9.1 12.10 16.70 0.012 1.998 (1.196-3.338) 0.008
STEMI 11.60 10.80 10.20 7.6 14.20 0.217 1.732 (0.841-3.567) 0.136
NSTEMI 11.80 8.5 8.2 16.00 16.40 0.022 2.297 (1.106-4.771) 0.026
*p for all comparisons, †p for the morning vs. evening group. AMI: acute myocardial infarction, OR: odds ratio, Cl: confidence interval, STEMI: 
ST-segment elevation myocardial infarction, NSTEMI: non-STEMI, HR: hazard ratioMyung Hwan Bae, et al.   623
ed the results of our study. Although the proportion of patients 
who arrived in the ER during routine duty hours was signifi-
cantly higher in the morning-onset group, there were no sig-
nificant differences in baseline characteristics between over-
night-, morning-, and afternoon-onset AMI groups. Overall, 
there was no significant difference in the 12-month mortality 
rate among these three groups.
It is well known that longer DTB time is an independent pre-
dictor of short- and long-term outcomes in patients with STE-
MI.
19)25) Although median DTB time in the STEMI subgroup 
was significantly longer among the evening-onset patients, the 
longer DTB time did not make a difference on 12-month mor-
tality in the present study.
One possible explanation for the discrepancy between pre-
vious studies and our finding is the different study population. 
Previous studies generally included patients who presented 
acutely to the hospital within 12 or 24 hours of symptom on-
set.
19)25) In this study, we included all consecutive patients with 
STEMI irrespective of the time from symptom onset to ER ar-
rival. We thought the impact of DTB time on short- and long-
term outcomes in patients with STEMI would be reduced be-
cause of the relatively long STD time. 
There are several limitations in this study. First, this was a sin-
gle-center observational study with a relatively small sample 
size. Second, multiple factors could affect the circadian varia-
tion and clinical outcome in this population. Finally, because 
timing of onset of AMI was self-reported by patients, they may 
have been assigned erroneously to particular groups.
In conclusion, there was a difference between the peak time 
of onset and 12-month mortality in patients with AMI. The 
twelve-month mortality rate was higher in the evening-onset 
AMI group compared to the morning-onset AMI group. Poor-
er baseline clinical characteristics included a higher Killip class, 
higher serum creatinine level, lower LVEF, and ER arrival dur-
ing off-duty hours in patients with evening-onset AMI. This 
might affect the circadian impact on 12-month mortality. We 
conclude that the time of AMI onset must be considered in the 
management of patients with AMI. Further studies are need-
ed to clarify the role of circadian variation on the long-term 
outcome of AMI.
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